MiR-23a expression was higher in patients with lymph node metastasis and metastatic cell lines and the treatment of TGF-β1 upregulated the expression of miR-23a in MCF-7 and MDA-MB-231 cell lines. Here, TGFB1 is linked to metastatic malignant neoplasm in the lymph nodes.